Capital Research Global Investors cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 45.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,552,672 shares of the medical equipment provider's stock after selling 1,302,661 shares during the period. Capital Research Global Investors owned 0.43% of Intuitive Surgical worth $694,401,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Rossmore Private Capital increased its holdings in shares of Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider's stock valued at $446,000 after purchasing an additional 20 shares during the last quarter. Activest Wealth Management raised its stake in Intuitive Surgical by 21.7% in the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider's stock valued at $50,000 after purchasing an additional 20 shares in the last quarter. Vertex Planning Partners LLC boosted its position in shares of Intuitive Surgical by 2.3% during the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider's stock worth $498,000 after acquiring an additional 21 shares in the last quarter. Accredited Investors Inc. increased its stake in shares of Intuitive Surgical by 2.0% in the 3rd quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider's stock valued at $474,000 after purchasing an additional 21 shares during the last quarter. Finally, SPC Financial Inc. raised its stake in Intuitive Surgical by 1.3% during the third quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider's stock worth $722,000 after acquiring an additional 21 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
ISRG has been the topic of several research reports. Wells Fargo & Company boosted their price target on Intuitive Surgical from $600.00 to $654.00 and gave the stock an "overweight" rating in a report on Friday, December 12th. Truist Financial boosted their target price on Intuitive Surgical from $620.00 to $650.00 and gave the company a "buy" rating in a research report on Thursday, December 18th. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an "outperform" rating on the stock in a report on Friday, January 23rd. The Goldman Sachs Group restated a "buy" rating and set a $714.00 price target on shares of Intuitive Surgical in a report on Friday, January 9th. Finally, UBS Group set a $570.00 target price on Intuitive Surgical and gave the stock a "neutral" rating in a research note on Tuesday, February 24th. Two analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average target price of $615.86.
View Our Latest Analysis on Intuitive Surgical
Insider Transactions at Intuitive Surgical
In related news, Director Gary S. Guthart sold 24,500 shares of the firm's stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares in the company, valued at $1,958,189.40. This trade represents a 86.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 421 shares of the business's stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president owned 409 shares in the company, valued at $202,438.64. The trade was a 50.72% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 37,802 shares of company stock worth $19,945,322. 0.70% of the stock is currently owned by corporate insiders.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $485.85 on Wednesday. The firm has a market cap of $172.54 billion, a P/E ratio of 61.58, a price-to-earnings-growth ratio of 3.81 and a beta of 1.66. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The business has a 50-day moving average of $518.26 and a 200 day moving average of $512.74.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter last year, the company earned $2.21 earnings per share. The company's revenue was up 18.8% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.